Immune response against SARS-CoV-2 of primary healthcare personnel in a commune of Santiago, Chile: follow-up at 6 months.
Olea Normandin, A.; Matute, I.; Hirmas, M.; Gonzalez-Wiedmaier, C.; Iruretagoyena, M.; Munita, J.; Pedroni, E.; Gomez, M. I.; Cortes, L. J.; Hormazabal, J.
Show abstract
BackgroundThe COVID-19 pandemic that emerged in Wuhan, China at the end of 2019, spread rapidly around the world with almost 600 million cases and 6.3 million deaths today. The most affected were health workers with at least three times the risk of contracting the disease than the general community. Most studies on seroprevalence in health workers focus on hospital care establishments and what happens in Primary Health Care (PHC) has not been investigated with the same intensity. Objectivesto determine the prevalence and know the variation of antibody titers for SARS-CoV-2 in serial samples of primary healthcare personnel from the commune of La Pintana. Methodan analytical observational study with a cross-sectional and a longitudinal component, carried out from November 2020 to June 2021. The first component consisted of an IgG antibody seroprevalence study performed at baseline (time 0) in volunteer of a universe of 900 workers. The longitudinal component considered the monitoring of IgG antibodies in those who presented a positive result at baseline and the analysis of neutralizing antibodies in a random sub-sample of 50% of them. Additionally, sociodemographic and clinical information was collected via a questionnaire. Univariate, bivariate, and longitudinal analyses were performed to evaluate differences in antibodies. The study was approved by the Universidad del Desarrollos Scientific Ethics Committee. Results463 primary healthcare workers participated, mostly women and with a median of 38 years; doctors and nurses represented 9.5% each and 14.7% had a history of COVID-19. The seroprevalence at baseline was 22.3% and was associated with younger age, being a doctor and having been in close contact of a case. IgG titers increased with the vaccine, but decreased over time. At the 6-month follow-up, 76% had neutralizing antibodies. Those belonging to indigenous peoples had higher IgG levels and higher rates of neutralizing antibodies. ConclusionHealthcare workers were highly affected by COVID-19, and the medical profession and younger age were factors associated with increased risk. Antibodies decrease over time, highlighting the importance of follow-up studies, as well as the importance of vaccination boosters in healthcare workers, especially those in PHC. FinancingThis project was funded by the Universidad del Desarrollo, COVID19-UDD 2020-21 Funds.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Serological Survey in a university community after the fourth wave of COVID-19 in Senegal 97%
- Epidemiological characterization of symptomatic and asymptomatic COVID-19 cases and positivity in subsequent RT-PCR tests in the United Arab Emirates 95%
- Serological prevalence of SARS-CoV-2 infection and associated factors in health care workers in a “non-COVID” hospital in Mexico City 95%
Similar papers in this journal
- Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine 96%
- COMPARATIVE IMMUNOGENICITY OF BNT162b2 mRNA VACCINE WITH NATURAL COVID-19 INFECTION 96%
- Tracking Immunity: Increased number of COVID-19 boosters increases the longevity of anti-RBD and anti-RBD neutralizing antibodies 95%
Similar papers in this journal
- Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina 95%
- Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley 95%
- Public Health response to an outbreak of SARS-CoV2 infection in a Barcelona prison 94%
Similar papers in this journal
- SARS-CoV-2 Seroprevalence among health care workers after the first and second pandemic wave 95%
- Can individuals with low antibody responses to vaccines against other viruses acquire adequate SARS-CoV-2 antibody after vaccination with the BNT162b2 mRNA vaccine? 94%
- Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France 94%
Similar papers in this journal
- Determinants of SARS-CoV-2 Vaccine Engagement in Algeria: A Population-based Study with Systematic Review of Studies from Arab Countries of the MENA Region 95%
- SARS-CoV-2 Seroprevalence and Risk Factors among Convalescents in Sichuan Province, China: a retrospective cohort study 95%
- Previous COVID-19 infection and antibody levels after vaccination 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.